glp-1 drug news today 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1R Race in 2025: 8

This action on bone metabolism caught the attention of several researchers in the area and has become a hot topic in recent years

Tramutola A, Arena A, Cini C, Butterfield DA, Barone E

New Indications : GLP-1 drugs are being tested for obesity-related conditions (NASH/non-alcoholic steatohepatitis, cardiovascular risk reduction, etc.)

If you are interested in semaglutide GLP-1 for weight loss, or if you are currently using it and have questions about long-term use, schedule a consultation with our medical team

There are currently no clinical trials investigating the use of GLP-1RAs in patients with PTSD or OCD, leaving the clinical validation of these findings unexplored

At the same time, overall spending on GLP-1 drugs has grown substantially, with national pharmacy spend rising more than 500 % from 2018 to 2023, underscoring the economic impact on payers and employers alike